Symdeko

DRUG2 trials

Sponsors

George Solomon, University of Alabama at Birmingham

Conditions

Cystic Fibrosis

Early Phase 1

Personalized Theratyping Trial

RecruitingNCT03587961

George SolomonCystic Fibrosis

Start: 2019-08-01End: 2027-09-01Target: 20Updated: 2026-02-02

Phase 4

Novel Therapeutic Approaches for Treatment of CF Patients With W1282X Premature Termination Codon Mutations

TerminatedNCT03624101

University of Alabama at BirminghamCystic Fibrosis

Start: 2018-12-01End: 2019-10-03Updated: 2025-04-16